Chiesi publicly reprimanded
December 13, 2013Sales and Marketing ABPI, Chiesi, PMCPA, fostair
Chiesi has had the book thrown at it by the PMCPA and faces the shame of a public reprimand – …
UK government creates apocalyptic app
December 13, 2013Medical Communications UK, digital, government, the walk
The Department of Health has this week released an Apple and Android game app designed to get the UK public …
Sanofi escapes most serious censure
December 13, 2013Medical Communications, Sales and Marketing ABPI, Lyxumia, PMCPA, Sanofi, censure
Sanofi has been cleared of the most serious breach of the ABPI Code of Practice – despite appearing to offer …
McCann Health names president of New York unit
December 13, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing duffy, mccann
Comms giant McCann Health has hired Susan Duffy to be president of its New York-based McCann Regan Campbell Ward (RCW). …
AstraZeneca donates doomed lab to Plymouth University
December 12, 2013Research and Development, Sales and Marketing AstraZeneca, lab, plymouth, university
AstraZeneca has pledged to donate its Devon-based Environmental Laboratory to Plymouth University, after announcing the site’s closure in October. The …
Ketchum head leaves amid job cuts
December 12, 2013Medical Communications Ketchum, comms, cuts, digital, sefton
The healthcare division of comms agency giant Ketchum is weathering a tough month following job cuts and a key resignation. …
€16 million fines for J&J and Novartis
December 12, 2013Medical Communications, Sales and Marketing EU, J&J, JJ, Novartis, Sandoz, fentanyl, fines
The European Commission has slapped multi-million euro fines on Johnson & Johnson and Novartis for what it says were ‘shocking’ …
GSK funnels another £200m into UK manufacturing
December 12, 2013Manufacturing and Production, Sales and Marketing GSK, Taylor, UK, manufacturing
GlaxoSmithKline has made good on a pledge to invest in UK-based production, with £200 million ($328m) earmarked for plant upgrades …
Priority review for Gaucher drug
December 12, 2013Sales and Marketing EMA, FDA, Gaucher, Genzyme, Sanofi
The FDA is to conduct a speedy investigation into Sanofi’s twice-daily oral candidate for Gaucher disease, which means that Cerdelga …
ABPI appoints nightclub owner as new NHS manager
December 12, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, NHS, nightclub, tugnet
The ABPI has appointed Raj Tugnet as its new NHS partnership manager to lead ABPI activities on academic health science …
Novo Nordisk faces police probe
December 11, 2013Medical Communications, Sales and Marketing FDA, Novo Nordisk, police
Novo Nordisk is facing an investigation from Denmark’s police over delaying the release of negative information it received from the …
UK government doubles dementia funding
December 11, 2013Research and Development, Sales and Marketing Alzheimer's, Cameron, Merck, Obama, dementia
UK prime minister David Cameron has announced that the government is to increase funding research into dementia, spending £52 million …
Twitter ‘drama’ produces drubbing for Medivir
December 11, 2013Medical Communications, Sales and Marketing Medivir, Twitter, digital, nasdaq
A NASDAQ disciplinary committee has found Medivir guilty of breaching its rules after data from a trial was posted on …
AbbVie posts strong results for Hep C pill
December 11, 2013Research and Development, Sales and Marketing 3D, AbbVie, FDA, Gilead, hep C
AbbVie’s investigational hepatitis C pill cured 96% of difficult-to-treat patients in a late-stage clinical trial and looks set to muscle …
Mike Nally replaces Deepak Khanna as MSD head
December 11, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Deepak Khanna, MSD, mike nally
Merck Sharp & Dohme has confirmed that Mike Nally will succeed Deepak Khanna as managing director for MSD in the …
PIP founder jailed for fraud
December 11, 2013Medical Communications, Sales and Marketing breast, implants, pip, silicone
The boss of a French firm at the centre of a global health scare over faulty breast implants has been …
Auto Injector Innovation: Quality and Compliance
December 11, 2013Manufacturing and Production auto injector, auto injector innovation, shl autoinjector
SHL recognizes the importance of this topic and discusses it in more details in an article titled “Auto Injector Innovation” …
Publicis acquires health analytics firm Verilogue
December 10, 2013Medical Communications Publicis Groupe, Veriogue, agency, comms
Publicis Groupe has acquired Verilogue, a healthcare analytics firm that specialises in doctor-patient communication. The US, Pennsylvania-based agency will now …
Cancer diagnosis is ‘national disgrace’
December 10, 2013Sales and Marketing CCGs, Cancer, NHS, appgc
Cancer care is still dangerously dependent on where patients in England live according to an influential group of MPs and …
Wii Fit Plus benefits patients with diabetes
December 10, 2013Medical Communications, Sales and Marketing bmc, diabetes, games, type 2, wii fit plus
A study says using interactive games through Nintendo’s Wii console helped type 2 diabetics to control their disease and improve …
Latest content
New CCO Ogburn joins Cori Clinical
Claris reports visual acuity gains with experimental LSCD treatment
Amphista doses first patient in AML trial of protein degrader
Jennings becomes President of Beckman Coulter Diagnostics
